DEFA14A: Amphastar Pharmaceuticals Corrects Proxy Statement Regarding Equity Incentive Plan Vote

Amphastar Pharmaceuticals issues a supplement to its proxy statement to correct an error in the voting standard for the proposed amendment and restatement of its 2015 Equity Incentive Plan.

Summary

• Amphastar Pharmaceuticals has filed a supplement to its definitive proxy statement dated April 12, 2024.
• The supplement addresses an error in the voting standard for Proposal 4, concerning the amendment and restatement of the 2015 Equity Incentive Plan.
• The correct voting standard, as stated on page 3 of the Proxy Statement, requires approval by a majority of the voting power of shares present or represented by proxy at the Annual Meeting with a quorum.
• Abstentions will be counted as votes against the proposal, while broker non-votes will have no effect.
• The supplement clarifies that it does not revise or update any other information in the original Proxy Statement.
• Stockholders who have already submitted their proxy do not need to take action unless they wish to change their vote, which can be done following instructions on page 4 of the Proxy Statement.

Sentiment

Score: 7

Explanation: The sentiment is neutral. The document is a correction of a clerical error, which is a standard corporate procedure. It doesn't indicate any positive or negative performance of the company.

Positives

• The company is proactively addressing and correcting an error in its proxy statement, ensuring accurate information for stockholders.
• Clear instructions are provided for stockholders who wish to change their vote.

Future Outlook

The supplement does not contain any forward-looking statements beyond the information provided in the original proxy statement.

Industry Context

This announcement is a routine correction to a proxy statement, which is a common occurrence in corporate governance. It ensures that shareholders have accurate information before voting on important company matters.

Stakeholder Impact

• Ensures shareholders have accurate information for informed voting decisions.

Next Steps

• Stockholders should review the supplement in conjunction with the original proxy statement before voting.
• Stockholders who wish to change their vote should follow the instructions provided in the proxy statement.

Key Dates

Keywords

Proxy Statement, Amphastar Pharmaceuticals, Equity Incentive Plan, Voting Standard, Annual Meeting, Amendment, Restatement